{"blog": [], "keywords": [{"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Medicaid", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Epinephrine (Drug)", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Centers for Medicare and Medicaid Services", "name": "organizations", "rank": "5", "is_major": "N"}, {"value": "Mylan Inc", "name": "organizations", "rank": "6", "is_major": "Y"}, {"value": "Generic Brands and Products", "name": "subject", "rank": "7", "is_major": "Y"}], "web_url": "http://www.nytimes.com/2016/09/03/business/is-epipen-a-brand-name-or-a-generic-drug-mylan-casts-it-both-ways.html", "document_type": "article", "byline": {"person": [{"lastname": "THOMAS", "firstname": "Katie", "role": "reported", "organization": "", "rank": 1}], "original": "By KATIE THOMAS"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "841", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "The drug company has listed the device as a generic to the government, possibly leading state Medicaid programs to overpay for it by millions of dollars.", "pub_date": "2016-09-03T00:02:16+0000", "news_desk": "Business", "headline": {"print_headline": "Is EpiPen a Brand-Name or a Generic Drug? Mylan Describes It Both Ways", "main": "Is EpiPen a Brand-Name or a Generic Drug? Mylan Casts It Both Ways"}, "print_page": "2", "snippet": "The drug company has listed the device as a generic to the government, possibly leading state Medicaid programs to overpay for it by millions of dollars....", "_id": "57ca131195d0e021d79842a3", "slideshow_credits": null, "abstract": "Revelations that number of state Medicaid programs have been overpaying Mylan Inc for its expensive EpiPen because company had been incorrectly advising federal officials that drug was generic brings fresh outrage; discovery raises questions about what other brand-name drugs may be similarly labeled generic, classification that gives manufacturer right to reduce discounts given to states on bulk purchase of drug."}